anecortave acetate has been researched along with Uveal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Filali, M; Homminga, I; Jager, MJ; Maat, W; van der Velden, PA | 1 |
| Alizadeh, H; Apte, R; Clark, AF; D'Orazio, TJ; Hegde, S; Leher, H; Li, XY; Ma, D; Mayhew, E; McLenaghan, A; Mellon, J; Niederkorn, JY | 1 |
2 other study(ies) available for anecortave acetate and Uveal Neoplasms
| Article | Year |
|---|---|
Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Eye Proteins; Humans; Melanoma; Nerve Growth Factors; Pregnadienediols; Serpins; Thrombospondin 1; Triamcinolone Acetonide; Uveal Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate.
Topics: Administration, Topical; Animals; Anterior Chamber; Cell Division; Female; Hydrocortisone; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured; Uveal Neoplasms | 1999 |